AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories
All
|
Back to Blog
Over the last decade, the radiotherapy devices market has seen significant technological advancements. These advancements have helped in the development of more effective, low-cost, and easy-to-use radiotherapy products with improved and precise radiation dose delivery to offer increased efficiency in targeting tumors. The advancement from 2D to 3D conformal radiotherapy with real-time imaging has enabled high conformity of radiation to the target (with minimal exposure to normal tissue) and dose escalation with improved tumor control.
What the market looks like? The radiotherapy market is projected to grow from an estimated USD 5.6 billion in 2018 to USD 6.8 billion by 2023, at a CAGR of 4.1%. Based on type, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy/brachytherapy, and systemic radiotherapy. The external beam radiotherapy segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can primarily be attributed to the reduced risk of radiation exposure in external beam radiotherapy and the increased precision and accuracy of tumor targeting in this therapy. Download PDF Brochure: Radiotherapy Market What drives the market? The growth of the global market for Radiotherapy is primarily influenced by the following factors: 1. Technological Advancements 2. Rising Prevalence of Cancer 3. Increasing Number of Conferences and Symposia Focusing on Spreading Awareness About the Benefits of Radiotherapy 4. Growing Use of Particle Therapy for Cancer Treatment 5. Emerging Markets The emerging markets, growing government and private investments to meet the increasing demand for cancer treatment, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players. Read more about Radiotherapy Market: https://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html
0 Comments
read more
Back to Blog
Rapid advances in technology have demonstrated the capability of terahertz spectroscopy in various healthcare applications. The focus on using terahertz spectroscopy in biomedical applications has increased rapidly, and several studies are being conducted to investigate its potential applications in pharmaceutical quality control, protein characterization, and cancer detection. T-rays are non-invasive and non-ionizing and thus can be focused harmlessly on the body to capture signs of cancer. Due to these advantages, terahertz spectroscopy is used in a number of cancer-related research activities. This is key factor increasing demand of molecular spectroscopy market.
What the Industry Looks Like? The global molecular spectroscopy market is expected to reach USD 6.85 billion by 2022 from USD 4.98 billion in 2017, at a CAGR of 6.6%. Pharmaceutical Application: Based on application, the molecular spectroscopy market is segmented into pharmaceutical applications, environmental testing, food and beverage testing, biotechnology and biopharmaceutical application, academic research and other applications. During the forecast period, the pharmaceutical application is expected to grow at the highest CAGR. This growth is mainly due to the growing importance of molecular spectroscopy in various stages of drug development and increasing R&D in pharmaceutical industries. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=50034395 Key Factors Driving Industry Growth: 1. Applications of Molecular Spectroscopy in Environmental Screening 2. Growing Use of Molecular Spectroscopy in Pharmaceutical & Biotechnology Industries 3. Technological Advancements in Molecular Spectroscopy Systems 4. Growing Focus on Ensuring the Quality of Food Products 5. Potential Applications of Terahertz Spectroscopy in Healthcare Key Players in Molecular Spectroscopy Market: Bruker (US), Thermo Fisher Scientific, Inc. (U.S), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Danaher Corporation (US), ABB (Switzerland), Merck KGaA (Germany), JEOL Ltd. (Japan), FOSS (Denmark), JASCO, Inc. (US), and HORIBA Ltd. (US) Bruker corporation, Inc. (U.S.) is one of the major player in the molecular spectroscopy market in 2016. The company provides a wide range of molecular spectroscopy technologies, accessories, and software in the market.
Back to Blog
Growth in the mass spectrometry market is primarily driven by factors such as government initiatives for pollution control and environmental testing, increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety, growing focus on the quality of food products, increase in crude and shale gas production, and technological advancements in mass spectrometers.
The mass spectrometry market is expected to grow from USD 4.6 billion in 2019 to USD 6.3 billion by 2024, at a CAGR of 6.7%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437 Pharmaceutical & Biotechnology applications held the largest share of the mass spectrometry market: Mass spectrometry is widely used for accurate analysis of small as well as large molecules in pharmaceuticals, forensic & clinical research, and other areas. The mass spectrometry applications market is segmented into pharmaceutical & biotechnology applications, environmental testing, food & beverage testing, petrochemical applications, and other applications. The pharmaceutical & biotechnology applications segment held the largest share of the market in 2019, a trend that is expected to continue during the forecast period. The large share of this segment can be attributed to the rise in demand for pharmaceutical biosimilars, phytopharmaceuticals, and regenerative medicine. North America is expected to hold a dominant share in the mass spectrometry market during the forecast period: North America held the largest share of the market in 2018 and is projected to continue to do so during the forecast period. Factors such as the growing funding for research and government initiatives in the US, widespread usage of mass spectrometry in the metabolomics and petroleum sector, and CFI funding towards mass spectrometry projects in Canada are driving the North American market. Get In-Depth Analysis of How COVID-19 is Impacting The Global Mass Spectrometry Market: 1. Covid Impact on Mass Spectrometry Market, growth/decline in product type/use cases of Mass Spectrometry Market due to cascaded impact of Covid on Extended Ecosystem. 2. How top 50 companies in Mass Spectrometry Market are making rapid shifts in their strategies. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=437 Key Players: The major vendors in the mass spectrometry industry market include SCIEX (US), Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), and Shimadzu Corporation (Japan). These leading players offer an expansive product portfolio for mass spectrometers and have a broad geographic presence.
Back to Blog
What are the key factors driving growth in global Molecular Spectroscopy Market?
The growth of molecular spectroscopy market is majorly driven by food safety concerns, the growth of the pharmaceutical and biotechnology industry, technological advancements in molecular spectroscopy and application of molecular spectroscopy in environmental screening. However, the high cost of equipment is likely to restrain the growth of the market during the forecast period. How global molecular spectroscopy industry will expand in coming years? The global molecular spectroscopy market is expected to reach USD 6.85 billion by 2022 from USD 4.98 billion in 2017, at a CAGR of 6.6%. The Pharmaceutical Application to Dominate The Industry: Based on application, the molecular spectroscopy market is segmented into pharmaceutical applications, environmental testing, food and beverage testing, biotechnology and biopharmaceutical application, academic research and other applications. During the forecast period, the pharmaceutical application is expected to grow at the highest CAGR. This growth is mainly due to the growing importance of molecular spectroscopy in various stages of drug development and increasing R&D in pharmaceutical industries. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=50034395 The Objective of Research is as Follows: 1. To define, describe, and forecast the global molecular spectroscopy market on the basis of product, application, end user, and region. 2. To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities and industry-specific challenges). 3. To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market. 4. To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders. 5. To forecast the size of the market with respect to five regions: North America, Europe, Asia Pacific, and the Rest of the world. Regional Analysis: Asia Pacific to witness the highest growth during the forecast period Asia Pacific is expected to grow at the highest CAGR in the global molecular spectroscopy market during the forecast period of 2017–2022. Thriving biotechnology market in China, growing focus on environmental protection, growing biomedical and medical research in Japan, and rising food safety concerns in India are expected to drive market growth during the forecast period. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=50034395 Key Players: Bruker (US), Thermo Fisher Scientific, Inc. (U.S), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Danaher Corporation (US), ABB (Switzerland), Merck KGaA (Germany), JEOL Ltd. (Japan), FOSS (Denmark), JASCO, Inc. (US), and HORIBA Ltd. (US)
Back to Blog
What are the key factors driving growth in Multiplex Assays Market?
In the current market scenario, there is a growing demand for multiplex assays. The major factors driving the growth of the market include the adoption of Companion Diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays. How global multiplex assays market will grow in coming years? The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.17 Billion in 2017, at CAGR of 7.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=61593314 Consumables Segment to Dominate The Market: On the basis of product & service, the market is broadly segmented into instruments, consumables, and software & services. The consumables segment is expected to account for the largest share of the market; it is also the fastest-growing segment of the multiplex assays market. This can be attributed to the recurring purchase of assays and reagents for increasing research applications. Which Geography to Create More Business Growth Opportunities? The APAC market is projected to register the highest growth rate during the forecast period primarily due to its pharmaceutical market, which is growing at the fastest pace in the world, the availability of a large number of qualified researchers, and increasing prevalence of cancer and infectious diseases. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=61593314 Key Market Players: The key players in the global multiplex assays market are Luminex (US), Bio-Rad Laboratories (US), Becton Dickinson (US), Illumina (US), and Thermo Fisher Scientific (US). Most companies focus on agreements, collaborations, and partnerships to compete in the market. The players also focus on increasing their presence in high-growth markets through acquisitions and product launches. Illumina (US), Luminex (US), and Bio-Rad Laboratories (US) focus on product launches, partnerships, and agreements to strengthen their position in the market. In 2017, Illumina was the leading player in the multiplex assays market. The company has a strong geographic presence across the US, Europe, Greater China, and Asia Pacific. The company focuses on offering consumables and analyzers in the multiplex assays market. Illumina concentrates on inorganic strategies to maintain its leader position in this market. For instance, in 2017, the company partnered with Integrated DNA Technologies (US) to provide improved library preparation multiplexing and target enrichment solutions for the next-generation sequencing (NGS) market. The agreement will see IDT and Illumina leveraging their expertise in the genomics field to deliver enhanced tools for sequencing. Similarly, in 2015, the company acquired GenoLogics Life Science Software Inc. (Canada) to integrate their life science software as part of the overall Illumina informatics solution. |